As from June 8, 2018, the equity rights in NeuroVive Pharmaceutical AB, NVP TO 5, will be admitted to trading on the list for Equity rights. Trading will continue up to and including November 28, 2018.
| Security name | Equity rights |
| Terms: |
One (1) subscription option entitles to the subscription of one (1) new share in NeuroVive Pharmaceutical AB. The subscription price for the shares upon exercise of the subscription options corresponds to SEK 3.80 per share. |
| Subscription period: | November 1, 2018 – November 30, 2018 |
| Short name | NVP TO 5 |
| Round lot | 1 |
| Clearing | Bilateral settlement at Euroclear Sweden |
| ISIN code | SE0010948778 |
| Orderbook ID | 155747 |
| Market Segment / no: | OMX STO Eq.rights,Subs.Opt, Int. shares/1 |
| Tick Size / no: | MiFID II tick size table / 230 |
| MIC Code: | XSTO |
For further information concerning this exchange notice please call Emelie Thordewall or Cecilia Olsson at + 46 8 405 60 00.